Singapore, July 24 -- Japan's Global Health Innovative Technology (GHIT) Fund has announced an investment of JPY 140 million (approximately $862,000) in a project to develop a portable rapid diagnostic system for Ebola disease.

The system is being jointly developed by Osaka Metropolitan University, K.K. DNAFORM (DNAFORM), and the National Institute for Biomedical Research (INRB) of the Democratic Republic of the Congo.

The project aims to advance rapid diagnostic technologies in response to Ebola outbreaks caused by the Bundibugyo virus in the Democratic Republic of the Congo and Uganda.

This investment covers approved early development milestones, including prototype development and performance validation for Bundibugyo virus detectio...